Today, too many never get one in time: fewer than 5% of new cancer drugs make it through clinical trials, and every failure costs patients precious time.
Orakl exists to change those odds.
We bridge biological and artificial intelligence by building large cohorts of virtual cancer patients, combining real patients' tumors with their medical histories and deep biological data.
By integrating patient-derived tumor models, experimental biology and AI, we help pharmaceutical companies predict how cancer drugs will perform in patients, identify promising treatments and make better decisions earlier in drug development.
Founded in 2023 by Fanny Jaulin, PhD, Diane-Laure Pagès, PhD, and Gustave Ronteix, PhD, Orakl is a spin-out of Gustave Roussy, one of Europe's leading cancer centres, building on a decade of research.
Backed by international investors, we are scaling our technology and partnerships with pharmaceutical companies worldwide.
Discover more at orakl-oncology.
comThe roleWe are looking for our first Communications, Brand & Events Lead to build Orakl's external presence from the ground up and establish the company as a leading voice in AI-driven cancer drug development.
Your job is to make the world understand what we are building, why it matters and why Orakl is uniquely positioned to lead this transformation.
You will shape how Orakl is perceived by the pharmaceutical companies we partner with, the scientists we want to attract, the investors backing us and the broader industry.
From defining our corporate narrative and building our reputation to securing media coverage and putting Orakl in the right rooms, you will turn our scientific and commercial progress into visibility, credibility and meaningful relationships.
You will own our communications, brand and events strategy, working directly with the founders and closely with our scientific, BD and Product Marketing teams.